关注
Nicholas Hornstein
Nicholas Hornstein
Oncology Fellow, MD Anderson Cancer Center
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Temporal Dynamics of Neuronal Activation by Channelrhodopsin-2 and TRPA1 Determine Behavioral Output in Drosophila Larvae
SR Pulver, SL Pashkovski, NJ Hornstein, PA Garrity, LC Griffith
Journal of neurophysiology 101 (6), 3075-3088, 2009
3122009
Ribosome profiling reveals a cell-type-specific translational landscape in brain tumors
C Gonzalez, JS Sims, N Hornstein, A Mela, F Garcia, L Lei, DA Gass, ...
Journal of Neuroscience 34 (33), 10924-10936, 2014
1252014
Widespread alterations in translation elongation in the brain of juvenile Fmr1 knockout mice
SD Sharma, JB Metz, H Li, BD Hobson, N Hornstein, D Sulzer, G Tang, ...
Cell reports 26 (12), 3313-3322. e5, 2019
702019
Ligation-free ribosome profiling of cell type-specific translation in the brain
N Hornstein, D Torres, S Das Sharma, G Tang, P Canoll, PA Sims
Genome biology 17, 1-15, 2016
612016
Optogenetics in the teaching laboratory: using channelrhodopsin-2 to study the neural basis of behavior and synaptic physiology in Drosophila
SR Pulver, NJ Hornstein, BL Land, BR Johnson
Advances in physiology education 35 (1), 82-91, 2011
462011
Channelrhodopsin2 mediated stimulation of synaptic potentials at Drosophila neuromuscular junctions
NJ Hornstein, SR Pulver, LC Griffith
JoVE (Journal of Visualized Experiments), e1133, 2009
262009
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44
AL Cummings, J Gukasyan, HY Lu, T Grogan, G Sunga, CM Fares, ...
Nature cancer 1 (12), 1167-1175, 2020
242020
Efficacy of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma: a randomized crossover trial
JP Shen, AM Yousef, FA Zeineddine, MA Zeineddine, RS Tidwell, ...
JAMA Network Open 6 (6), e2316161-e2316161, 2023
102023
Factors associated with hospitalization among breast cancer patients with COVID-19: a diverse multi-center Los Angeles cohort study
N Kathuria-Prakash, L Antrim, N Hornstein, AW Sun, IM Kang, NV Baclig, ...
Clinical breast cancer 22 (4), e558-e566, 2022
62022
Widespread alterations in translation elongation in the brain of juvenile Fmr1 knockout mice. Cell Rep. 26, 3313–3322. e5
S Das Sharma, JB Metz, H Li, BD Hobson, N Hornstein, D Sulzer, G Tang, ...
62019
High-throughput translational profiling with riboPLATE-seq
JB Metz, NJ Hornstein, SD Sharma, J Worley, C Gonzalez, PA Sims
Scientific Reports 12 (1), 5718, 2022
52022
Nivolumab treatment of Burkitt lymphoma: a case report
BS Colton, N Hornstein, J Timmerman, S Larson, J Glaspy
Annals of Internal Medicine 174 (4), 567-568, 2021
42021
A prospective randomized crossover trial of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma
JP Shen, AM Yousef, FA Zeineddine, MA Zeineddine, RS Tidwell, ...
medRxiv, 2022.12. 06.22283164, 2022
22022
The natural history of a patient with COVID-19 pneumonia and silent hypoxemia
N Hornstein, GM Jaffe, K Chuang, J Betancourt, GWS Hoo
Federal Practitioner 38 (4), 184, 2021
12021
Efficacy and safety of atezolizumab and bevacizumab in appendiceal adenocarcinoma
NJ Hornstein, MA Zeineddine, BB Gunes, AJ Pellatt, M Knafl, H Zhu, ...
Cancer Research Communications 4 (5), 1363-1368, 2024
2024
Cell-type-specific gene programs suggest immune and stromal drivers of relapse in colorectal cancer
NJ Hornstein, M Wang, A Yousef, S Chowdhury, F Zeineddine, ...
Cancer Research 84 (6_Supplement), 881-881, 2024
2024
Identification of colorectal cancer cell stemness from single-cell RNA sequencing
K Lin, S Chowdhury, MA Zeineddine, FA Zeineddine, NJ Hornstein, ...
Molecular Cancer Research, OF1-OF10, 2024
2024
Single cell transcriptomic profiling of appendiceal adenocarcinoma to identify rare tumor cells and a myeloid-enriched tumor microenvironment (TME).
BB Gunes, NJ Hornstein, M Wang, S Chowdhury, MMG Yousef, ...
Journal of Clinical Oncology 42 (3_suppl), 760-760, 2024
2024
27P Extending a classification system for atypical BRAF mutations to improve targeted therapies in colorectal cancer cells
AB Madduri, Y Liu, BG Nelson, KE Sanders, D Wang, N Hornstein, J Shen
Annals of Oncology 34, S195, 2023
2023
Abstract CT148: Efficacy, safety, and biomarker analysis of combined MEK (Cobimetinib) and PD-L1 (Atezolizumab) inhibition (COTEZO) in advanced small bowel adenocarcinoma (SBA)
N Hornstein, JP Shen, AJ Pellatt, S Liu, M Knafl, AF Willett, H Zhu, ...
Cancer Research 83 (8_Supplement), CT148-CT148, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20